Insider Trading & Ownership - ADAMS ADRIAN

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ADAMS ADRIAN
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-08-18
Purchase
2021-08-19
5:23 pm
IMPEL NEUROPHARMA INCIMPLADAMS ADRIAN
COB, CEO and President
20,000$13.99$279,79020,000
(Direct)
View
2020-06-15
Purchase(A)
2020-06-15
6:39 pm
ACELRX PHARMACEUTICALS INCACRXADAMS ADRIAN
Director
100,000$1.289$128,900178,750
(Direct)
View
2020-06-15
Purchase
2020-06-15
6:01 pm
ACELRX PHARMACEUTICALS INCACRXADAMS ADRIAN
Director
100,000$1.289$128,900178,750
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-24
Option Award
2024-06-24
7:12 pm
N/A
2034-06-23
TALPHERA INC.TLPHADAMS ADRIAN
Director
15,218$026,386
(Direct)
View
2024-06-06
Option Award
2024-06-10
4:18 pm
2025-06-06
2034-06-06
Akebia Therapeutics Inc.AKBAADAMS ADRIAN
Director
75,000$0209,800
(Direct)
View
2023-10-10
Option Award
2023-12-13
4:19 pm
2024-10-10
2033-10-10
ACELRX PHARMACEUTICALS INCACRXADAMS ADRIAN
Director
4,068$014,655
(Direct)
View
2023-06-06
Option Award
2023-06-08
4:07 pm
2024-06-06
2033-06-06
Akebia Therapeutics Inc.AKBAADAMS ADRIAN
Director
75,000$0179,800
(Direct)
View
2023-02-14
Option Award
2023-02-16
6:19 pm
N/A
2033-02-13
IMPEL PHARMACEUTICALS INCIMPLADAMS ADRIAN
COB, CEO and President
200,000$0200,000
(Direct)
View
2022-07-15
Option Award
2022-07-15
7:31 pm
2022-07-15
2032-07-14
ACELRX PHARMACEUTICALS INCACRXADAMS ADRIAN
Director
46,500$0242,750
(Direct)
View
2022-06-08
Option Award
2022-06-09
4:56 pm
2023-06-08
2032-06-08
Akebia Therapeutics Inc.AKBAADAMS ADRIAN
Director
33,800$0124,900
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:01 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLADAMS ADRIAN
COB, CEO and President
175,000$0175,000
(Direct)
View
2021-07-20
Option Award
2021-07-26
5:58 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INCIMPLADAMS ADRIAN
COB, CEO and President
50,000$050,000
(Direct)
View
2021-06-17
Option Award
2021-06-17
5:32 pm
2022-06-17
2031-06-16
ACELRX PHARMACEUTICALS INCACRXADAMS ADRIAN
Director
30,000$0216,250
(Direct)
View
2021-06-02
Option Award
2021-06-03
5:27 pm
2022-06-02
2031-06-02
Akebia Therapeutics Inc.AKBAADAMS ADRIAN
Director
33,800$0111,200
(Direct)
View

Ownership
2021-04-22
7:01 pm
N/A
2030-01-22
IMPEL NEUROPHARMA INCIMPLADAMS ADRIAN
COB, CEO and President
0$0795,546
(Direct)
View
2020-06-16
Option Award
2020-06-16
7:13 pm
2021-06-16
2030-06-15
ACELRX PHARMACEUTICALS INCACRXADAMS ADRIAN
Director
22,500$0201,250
(Direct)
View
2020-06-05
Option Award
2020-06-09
4:16 pm
2021-06-05
2030-06-05
Akebia Therapeutics Inc.AKBAADAMS ADRIAN
Director
33,800$097,500
(Direct)
View
(A) Indicate amendment filing.